Newsletter | February 9, 2024

02.09.24 -- Meeting The Demand For Cell & Gene Therapy Commercialization

Accelerating The Delivery Of Innovative Cell Therapies

Gain insight into BioCentriq as a collaborative CDMO specializing in cell and gene therapies. Learn more about the company, their capabilities, and their leadership team.

Request Information


Your Full-Spectrum Gene Therapy Partner

Andelyn Biosciences is your full-spectrum gene therapy partner. Work with us from start to finish of your product or partner with us at any stage of your project – preclinical through commercial scale.

Request Information

Andelyn Biosciences

Cell Therapy CDMO Services Tailored To Your Needs

Leveraging the technology, expertise, and capacity of a cell therapy CDMO is crucial to reduce timelines and lower costs as you bring your novel cell therapy from discovery to commercialization.

Request Information

Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises

Plasmid Manufacturing For Gene Therapies

Dr. Katya McLane and Ron Chantung of Ajinomoto Bio-Pharma Services answer questions on optimizing, scaling-up, and manufacturing plasmids for clinical and commercial success.

Request Information

Ajinomoto Bio-Pharma Services

CRISPR/Cas Nucleases Product Guide

Discover how manufacturing research grade Cas enzymes in an ISO 13485 certified facility enables a seamless transition to a cGMP product as you progress into the clinic.

Request Information


Integrated Cell Therapy Manufacturing Services

Our team has unparalleled prior experience in advancing cell therapies to IND and to commercialization. Clients can leverage our large single-site facility, capable of fully integrated production.

Request Information

The Center for Breakthrough Medicines

CGT Solutions Brochure

Leveraging a partner with expertise and integrated, end-to-end solutions can help overcome obstacles to increase patient access and ensure the safe distribution of your advanced therapy product.

Request Information


Technologies That Smartly Scale iPSC To Benefit Human Health

Learn how leveraging a GMP-like environment even in early R&D stages is crucial for setting your cell therapy up for success as you advance toward IND and NDA approvals.

Request Information


UpTempo AAV Platform Process

Catalent’s UpTempo AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.

Request Information


Cell Therapy Capabilities

Our teams of scientists have 30 years of cell therapy development, manufacturing, and regulatory experience. We support every stage of the product journey, from pre-clinical through commercialization.

Request Information

AGC Biologics

Advanced Therapy Solutions

Learn how the right partner can help you overcome regulatory and financial complexities of advanced therapies and ensure product quality and safety through robust logistics support.

Request Information

Cardinal Health

Cell Therapy CDMO Services

A trusted partner with the insight and experience to take your cell and gene therapy products from bench to bedside. We know how to accelerate and help you achieve your cell and gene therapy goals.

Request Information

Charles River

End-To-End Capabilities

We have the expertise, technologies, and state-of-the-art facilities to deliver cell and gene therapies from concept through commercialization, all under a single roof, right from the start.

Request Information